IPF Disease and Syndrome Study
Part of Lungs & breathing clinical trials.
This study looks at the features of idiopathic pulmonary fibrosis (IPF) and the traditional Chinese medicine patterns that go with it. If you have IPF, you may be able to join to help researchers understand the disease better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with IPF (idiopathic pulmonary fibrosis).
- You are 18 years old or older.
- You are willing to take part and sign a consent form.
- You do not have confusion, dementia, or other serious mental health conditions that would affect participation.
- You are able to care for yourself and are not confined to bed long-term.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with idiopathic pulmonary fibrosis (IPF, a lung scarring disease) to see how traditional Chinese medicine (TCM) might help. You may be able to join if you are at least 40 years old and willing to take part.
This study looks at genetic (inherited) factors related to pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF). It may help researchers understand why some families are more affected and could guide future testing or treatments.
This trial tests a new drug called BC006 for people with idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring. The goal is to see if it can help improve lung function. You may be eligible if you are 40 or older and have a confirmed IPF diagnosis with specific lung test results.
This Phase 2 study tests whether an oral medication (INS018_055) can help people with idiopathic pulmonary fibrosis (IPF). You may be a fit if your lung function is in a certain range and your condition is stable.
This study follows people with interstitial lung disease to learn more about how Chinese medicine can help. If you have ILD and are 18 or older, you may be able to join.
This study looks at how idiopathic pulmonary fibrosis (IPF) is diagnosed and treated, and how it affects patients' daily lives. It aims to learn from both patients and their doctors to improve care.
Hear when a new Idiopathic Pulmonary Fibrosis (IPF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.